Our data identified a significant association between biomarkers of neuroinflammation, such as CRP, IL-6, or TNF-α, and the risk of delirium, but further research is needed to standardize the methodology, improve scientific evidence and translate the current knowledge into pragmatic tools for routine clinical practice in the field of delirium. The gene discussed is IL6; the disease is delirium.